Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jolanta Malyszko

Showing results (1-10 of 201) with videos related to

Pageof 21
Sort By:
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 6, 2010
Mechanism of endothelial dysfunction in chronic kidney diseaseJolanta Malyszko
Expert Opinion on Emerging Drugs|December 19, 2013
New renal anemia drugs: is there really anything new on the horizon?Jolanta Malyszko
Kidney & Blood Pressure Research|October 7, 2010
Biomarkers of acute kidney injury in different clinical settings: a time to change the paradigm?Jolanta Malyszko
Expert Opinion on Therapeutic Targets|November 29, 2013
New therapeutic perspectives on protein-bound uremic toxins in chronic kidney diseaseJolanta Malyszko
Kidney & Blood Pressure Research|March 17, 2009
Hemojuvelin: the hepcidin story continuesJolanta Malyszko
Current Vascular Pharmacology|May 1, 2013
Pre-CKD- do we need another hero?Jolanta Malyszko, Maciej Banach
Advances in Medical Sciences|June 28, 2020
Iron, ferroptosis, and new insights for prevention in acute kidney injuryBartlomiej Borawski, Jolanta Malyszko
Journal of Nephrology|November 22, 2023
Continuous glucose monitoring in people with diabetes and end-stage kidney disease-review of association studies and Evidence-Based discussionZuzanna Jakubowska, Jolanta Malyszko
Kidney & Blood Pressure Research|January 12, 2007
Hepcidin in anemia and inflammation in chronic kidney diseaseJolanta Malyszko, Michal Mysliwiec
Contemporary Oncology (Poznan, Poland)|November 16, 2022
Acute kidney injury prevalence in patients with colorectal cancer undergoing surgery with curative intentLeszek Kozlowski, Jolanta Malyszko
Pageof 21

Showing results (1-10 of 201) with videos related to

Sort By:
Pageof 21
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 6, 2010
Mechanism of endothelial dysfunction in chronic kidney diseaseJolanta Malyszko
Expert Opinion on Emerging Drugs|December 19, 2013
New renal anemia drugs: is there really anything new on the horizon?Jolanta Malyszko
Kidney & Blood Pressure Research|October 7, 2010
Biomarkers of acute kidney injury in different clinical settings: a time to change the paradigm?Jolanta Malyszko
Expert Opinion on Therapeutic Targets|November 29, 2013
New therapeutic perspectives on protein-bound uremic toxins in chronic kidney diseaseJolanta Malyszko
Kidney & Blood Pressure Research|March 17, 2009
Hemojuvelin: the hepcidin story continuesJolanta Malyszko
Current Vascular Pharmacology|May 1, 2013
Pre-CKD- do we need another hero?Jolanta Malyszko, Maciej Banach
Advances in Medical Sciences|June 28, 2020
Iron, ferroptosis, and new insights for prevention in acute kidney injuryBartlomiej Borawski, Jolanta Malyszko
Journal of Nephrology|November 22, 2023
Continuous glucose monitoring in people with diabetes and end-stage kidney disease-review of association studies and Evidence-Based discussionZuzanna Jakubowska, Jolanta Malyszko
Kidney & Blood Pressure Research|January 12, 2007
Hepcidin in anemia and inflammation in chronic kidney diseaseJolanta Malyszko, Michal Mysliwiec
Contemporary Oncology (Poznan, Poland)|November 16, 2022
Acute kidney injury prevalence in patients with colorectal cancer undergoing surgery with curative intentLeszek Kozlowski, Jolanta Malyszko
Pageof 21